Aenitis Technologies

About:

Aenitis Technologies is a French start-up resulting from the work of Mauricio HOYOS

Website: http://www.aenitis.fr/

Top Investors: European Innovation Council, Seventure Partners, AGORANOV, EASME - EU Executive Agency for SMEs, WILCO

Description:

Created in July 2014, Aenitis Technologies is a French start-up resulting from the work of Mauricio HOYOS and Jean-Luc AIDER, both CNRS researchers at the PMMH Laboratory (Physics and Mechanics of Heterogeneous Media at the ESPCI ParisTech, a research engineer’s school in Paris. The company focuses on medical devices’ area, where their breakthrough technologies are highly promising. Aenitis Technologies is developing innovative separation, manipulation and filtration of biological elements solutions, based on acoustophoresis technologies. The company first focuses on technological solutions that will revolutionize current practices in Public Health. Aenitis Technologies aims to become a world leader in filtering / separating solutions by acoustophoresis.

Total Funding Amount:

4.17M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Paris, Ile-de-France, France

Founded Date:

2014-01-01

Contact Email:

contact(AT)aenitis.fr

Founders:

Emmanuel VINCENT, Jean-Luc Aider, Philippe Tramoy

Number of Employees:

1-10

Last Funding Date:

2024-10-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai